Health · 19 views
People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds
Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot…
AI Summary
A clinical trial called SINGLE‑AF found that oral anticoagulant therapy reduced the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation who have an intermediate risk of stroke. The results were presented during a Hot Line session at the ESC Congress 2026 and were published simultaneously in the New England Journal of Medicine.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patientsContinue reading
- Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar rangeContinue reading
- Wearing headphones during surgery may reduce nausea and vomiting afterwardContinue reading
- Adult ADHD; Encouraging Advance Care Planning; Hospital Closures in the U.S.Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow